Cory Renauer
Cory Renauer is a contributing Motley Fool healthcare analyst covering pharmaceuticals, biotechnology, and medical devices. Previously, Cory was a laboratory technician for the American Red Cross. He holds a bachelor’s degree in biology from Oakland University.
Recent Articles by Cory Renauer

Mar 15, 2025
by Cory Renauer
Down 93%, Is It Finally Time to Buy Moderna?

Mar 11, 2025
by Cory Renauer
Down 62%. Should You Buy TransMedics Stock on the Dip?

Mar 5, 2025
by Cory Renauer
Down 39%. Is Novo Nordisk Stock a Buy on the Dip?

Feb 10, 2025
by Cory Renauer
Better High-Yield Dividend Stock: Pfizer vs. Merck
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.